EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?

Broncho-pulmonary neuroendocrine neoplasms (BP-NENs) are neoplasms orphan of an efficient therapy. Available medical treatments derived from clinical trials are not specific for the management of this malignancy. Sunitinib is a multi-receptor tyrosine-kinases (RTKs) inhibitor that has already shown...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Endocr Connect
Main Authors: Bresciani, Giulia, Ditsiou, Angeliki, Cilibrasi, Chiara, Vella, Viviana, Rea, Federico, Schiavon, Marco, Cavallesco, Narciso Giorgio, Giamas, Georgios, Zatelli, Maria Chiara, Gagliano, Teresa
Format: Artigo
Sprog:Inglês
Udgivet: Bioscientifica Ltd 2019
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6528406/
https://ncbi.nlm.nih.gov/pubmed/31035254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-19-0192
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker